The FDA has approved Leqembi Iqlik (lecanemab-irmb) subcutaneous weekly starting dose, enabling fully at-home treatment ...

Prospectively documented childhood abuse is associated with a significantly increased long-term risk for adult migraine in men, and depression seems to partially mediate this rela ...

Adults with elevated emotional dysfunction report higher current ADHD symptoms regardless of an actual ADHD diagnosis.

The use of benzodiazepines among older adults in the US decreased and then plateaued after the COVID-19 pandemic.

The FDA accepted the NDA for AXS-12 (reboxetine) for the treatment of cataplexy in narcolepsy, setting a PDUFA target action date of May 1, 2027.

The proportion of suspected suicide attempts vs all emergency department visits decreased between 2021 and 2025.

Virtual military sexual trauma-focused group therapy improves post-traumatic stress disorder symptoms in veterans.

Increased duration of full breastfeeding may reduce the presentation of ADHD symptoms in children aged 3, 5, and 8 years.

Prefrontal transcranial pulse stimulation offers some antidepressant effects among patients with major depressive disorder.

Twice-daily stable lithium carbonate dosing seems to offer more stable brain lithium levels among euthymic individuals with bipolar disorder.

Among adults with mood and psychotic disorders, sodium-glucose cotransporter 2 inhibitor use are associated with a lower risk for dementia.

Many young adults are not engaging with primary care compared with health care use patterns seen in previous generations.